The Efficacy of Combined Exosome (Exodew) and Microneedling Treatment for Facial Pore Reduction and Skin Texture Improvement.

IF 1.5 Q3 SURGERY
Plastic and Reconstructive Surgery Global Open Pub Date : 2025-06-05 eCollection Date: 2025-06-01 DOI:10.1097/GOX.0000000000006849
Jovian Wan, Song Eun Yoon, Kyu-Ho Yi
{"title":"The Efficacy of Combined Exosome (Exodew) and Microneedling Treatment for Facial Pore Reduction and Skin Texture Improvement.","authors":"Jovian Wan, Song Eun Yoon, Kyu-Ho Yi","doi":"10.1097/GOX.0000000000006849","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Enlarged facial pores are a common aesthetic concern that worsens with age due to increased sebum production, reduced skin elasticity, and photoaging. Although microneedling is known to stimulate collagen production, the combined use of stem cell-derived exosome therapy for pore reduction has not been thoroughly investigated.</p><p><strong>Methods: </strong>A case series was conducted at a private aesthetic clinic between January and June 2024. Three patients (1 man and 2 women; 32-55 y of age; Fitzpatrick skin type IV) underwent 3 sessions of microneedling combined with topical exosome application (Exodew, Hyundae Meditech) at 4-week intervals. Standardized photographs were obtained at baseline and posttreatment. Clinical outcomes were evaluated using the Global Aesthetic Improvement Scale by 2 independent dermatologists and patient satisfaction scores at 12 and 22 weeks.</p><p><strong>Results: </strong>All patients exhibited visible reductions in pore size and improvements in skin texture and overall appearance. Global Aesthetic Improvement Scale scores ranged from 4 to 5, indicating \"very much improved\" outcomes. Patient satisfaction was high at both 12- and 22-week follow-ups. No adverse events were reported, and improvements were sustained through week 22.</p><p><strong>Conclusions: </strong>Microneedling combined with stem cell-derived exosome therapy seems to be a safe and effective treatment for facial pore reduction and skin texture enhancement. Larger, controlled studies are needed to confirm these preliminary results.</p>","PeriodicalId":20149,"journal":{"name":"Plastic and Reconstructive Surgery Global Open","volume":"13 6","pages":"e6849"},"PeriodicalIF":1.5000,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12140750/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Plastic and Reconstructive Surgery Global Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/GOX.0000000000006849","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Enlarged facial pores are a common aesthetic concern that worsens with age due to increased sebum production, reduced skin elasticity, and photoaging. Although microneedling is known to stimulate collagen production, the combined use of stem cell-derived exosome therapy for pore reduction has not been thoroughly investigated.

Methods: A case series was conducted at a private aesthetic clinic between January and June 2024. Three patients (1 man and 2 women; 32-55 y of age; Fitzpatrick skin type IV) underwent 3 sessions of microneedling combined with topical exosome application (Exodew, Hyundae Meditech) at 4-week intervals. Standardized photographs were obtained at baseline and posttreatment. Clinical outcomes were evaluated using the Global Aesthetic Improvement Scale by 2 independent dermatologists and patient satisfaction scores at 12 and 22 weeks.

Results: All patients exhibited visible reductions in pore size and improvements in skin texture and overall appearance. Global Aesthetic Improvement Scale scores ranged from 4 to 5, indicating "very much improved" outcomes. Patient satisfaction was high at both 12- and 22-week follow-ups. No adverse events were reported, and improvements were sustained through week 22.

Conclusions: Microneedling combined with stem cell-derived exosome therapy seems to be a safe and effective treatment for facial pore reduction and skin texture enhancement. Larger, controlled studies are needed to confirm these preliminary results.

外泌体(Exodew)和微针联合治疗面部毛孔减少和皮肤质地改善的疗效。
背景:面部毛孔粗大是一种常见的审美问题,随着年龄的增长,由于皮脂分泌增加,皮肤弹性降低和光老化,毛孔粗大会恶化。虽然已知微针可以刺激胶原蛋白的产生,但干细胞来源的外泌体治疗毛孔缩小的联合使用尚未得到彻底的研究。方法:于2024年1月至6月在一家私人美容诊所进行病例系列调查。3例患者(1男2女);年龄32-55岁;Fitzpatrick皮肤IV型)每隔4周进行3次微针联合局部外泌体应用(Exodew, hyundai Meditech)。在基线和治疗后获得标准化照片。临床结果由2名独立皮肤科医生使用全球美容改善量表和患者满意度评分在12周和22周进行评估。结果:所有患者都表现出明显的毛孔缩小和皮肤质地和整体外观的改善。全球审美改善量表得分范围从4到5,表明“非常改善”的结果。在12周和22周的随访中,患者的满意度都很高。无不良事件报告,改善持续到第22周。结论:微针联合干细胞来源的外泌体治疗是一种安全有效的面部毛孔缩小和皮肤纹理增强的治疗方法。需要更大规模的对照研究来证实这些初步结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.20
自引率
13.30%
发文量
1584
审稿时长
10 weeks
期刊介绍: Plastic and Reconstructive Surgery—Global Open is an open access, peer reviewed, international journal focusing on global plastic and reconstructive surgery.Plastic and Reconstructive Surgery—Global Open publishes on all areas of plastic and reconstructive surgery, including basic science/experimental studies pertinent to the field and also clinical articles on such topics as: breast reconstruction, head and neck surgery, pediatric and craniofacial surgery, hand and microsurgery, wound healing, and cosmetic and aesthetic surgery. Clinical studies, experimental articles, ideas and innovations, and techniques and case reports are all welcome article types. Manuscript submission is open to all surgeons, researchers, and other health care providers world-wide who wish to communicate their research results on topics related to plastic and reconstructive surgery. Furthermore, Plastic and Reconstructive Surgery—Global Open, a complimentary journal to Plastic and Reconstructive Surgery, provides an open access venue for the publication of those research studies sponsored by private and public funding agencies that require open access publication of study results. Its mission is to disseminate high quality, peer reviewed research in plastic and reconstructive surgery to the widest possible global audience, through an open access platform. As an open access journal, Plastic and Reconstructive Surgery—Global Open offers its content for free to any viewer. Authors of articles retain their copyright to the materials published. Additionally, Plastic and Reconstructive Surgery—Global Open provides rapid review and publication of accepted papers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信